• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自闭症和广泛性发育障碍中行为症状的药物治疗。

Pharmacologic treatment of behavioral symptoms in autism and pervasive developmental disorders.

作者信息

Findling Robert L

机构信息

Division of Child and Adolescent Psychiatry, University Hospitals of Cleveland, Case Western Reserve University, Cleveland, Ohio, USA.

出版信息

J Clin Psychiatry. 2005;66 Suppl 10:26-31.

PMID:16401147
Abstract

Autism and other pervasive developmental disorders (PDDs) are associated with various dysfunctional and problematic behaviors, in addition to the core features of language and social skills dysfunction that define these conditions. Although there is currently no pharmacologic cure for the core features of PDDs, some of the behavioral symptoms may be treated pharmacologically. In addition to relieving some of the daily stress in the lives of patients and their families, improvement of these behavioral symptoms, which include hyperactivity, aggression, tantrums, and self-injury, removes some of the hindrances to other rehabilitative efforts. This article discusses the efficacy and tolerability of various medications and alternative interventions in addressing the symptoms of autism and other PDDs.

摘要

自闭症和其他广泛性发育障碍(PDDs)除了具有定义这些病症的语言和社交技能功能障碍等核心特征外,还与各种功能失调和问题行为相关。虽然目前尚无针对PDDs核心特征的药物治疗方法,但某些行为症状可以通过药物治疗。除了缓解患者及其家人生活中的一些日常压力外,改善这些行为症状,包括多动、攻击行为、发脾气和自我伤害等,还能消除其他康复努力的一些障碍。本文讨论了各种药物和替代干预措施在治疗自闭症和其他PDDs症状方面的疗效和耐受性。

相似文献

1
Pharmacologic treatment of behavioral symptoms in autism and pervasive developmental disorders.自闭症和广泛性发育障碍中行为症状的药物治疗。
J Clin Psychiatry. 2005;66 Suppl 10:26-31.
2
Pharmacotherapy of irritability in pervasive developmental disorders.广泛性发育障碍中易激惹症状的药物治疗
Child Adolesc Psychiatr Clin N Am. 2008 Oct;17(4):739-52, vii-viii. doi: 10.1016/j.chc.2008.06.002.
3
Pharmacological treatment options for autism spectrum disorders in children and adolescents.儿童和青少年自闭症谱系障碍的药物治疗选择
Harv Rev Psychiatry. 2008;16(2):97-112. doi: 10.1080/10673220802075852.
4
Role of risperidone in children with autism spectrum disorder.利培酮在自闭症谱系障碍儿童中的作用。
Ann Pharmacother. 2006 May;40(5):909-16. doi: 10.1345/aph.1G389. Epub 2006 Mar 7.
5
Managing irritability and aggression in autism spectrum disorders in children and adolescents.应对儿童和青少年自闭症谱系障碍中的易怒和攻击行为。
Dev Disabil Res Rev. 2010;16(3):258-64. doi: 10.1002/ddrr.118.
6
Psychopharmacology of autism spectrum disorders: a selective review.自闭症谱系障碍的精神药理学:选择性综述。
Autism. 2013 Nov;17(6):645-54. doi: 10.1177/1362361312453776. Epub 2012 Aug 14.
7
Psychopharmacology in childhood disorders.儿童疾病中的精神药理学。
Psychiatr Clin North Am. 1984 Dec;7(4):831-43.
8
Safety issues with drug therapies for autism spectrum disorders.自闭症谱系障碍药物治疗的安全性问题。
J Clin Psychiatry. 2005;66 Suppl 10:32-7.
9
Use of medication in pervasive developmental disorders.药物在广泛性发育障碍中的应用。
Psychiatr Clin North Am. 1991 Mar;14(1):165-82.
10
Risperidone: a potential treatment for autism.利培酮:一种治疗自闭症的潜在方法。
Curr Opin Investig Drugs. 2002 Aug;3(8):1212-6.

引用本文的文献

1
Pharmacological intervention of behavioural traits and brain histopathology of prenatal valproic acid-induced mouse model of autism.药物干预自闭症胎儿暴露于丙戊酸模型鼠的行为特征及脑组织病理学改变
PLoS One. 2024 Sep 24;19(9):e0308632. doi: 10.1371/journal.pone.0308632. eCollection 2024.
2
Role of Neuroinflammation in Autism Spectrum Disorder and the Emergence of Brain Histaminergic System. Lessons Also for BPSD?神经炎症在自闭症谱系障碍及脑组胺能系统出现中的作用。对行为和心理症状的痴呆症也有启示?
Front Pharmacol. 2020 Jun 16;11:886. doi: 10.3389/fphar.2020.00886. eCollection 2020.
3
Pharmacotherapy of ADHD in Adults With Autism Spectrum Disorder: Effectiveness and Side Effects.
成人自闭症谱系障碍的注意缺陷多动障碍药物治疗:疗效和副作用。
J Atten Disord. 2020 Jan;24(2):215-225. doi: 10.1177/1087054719866255. Epub 2019 Oct 18.
4
The histamine H3R antagonist DL77 attenuates autistic behaviors in a prenatal valproic acid-induced mouse model of autism.组胺 H3R 拮抗剂 DL77 可减轻丙戊酸诱导的自闭症小鼠模型的自闭症行为。
Sci Rep. 2018 Aug 30;8(1):13077. doi: 10.1038/s41598-018-31385-7.
5
Early Social Enrichment Improves Social Motivation and Skills in a Monogenic Mouse Model of Autism, the Oprm1 (-/-) Mouse.早期社会丰富化改善自闭症单基因小鼠模型Oprm1(-/-)小鼠的社会动机和技能。
Neural Plast. 2016;2016:5346161. doi: 10.1155/2016/5346161. Epub 2016 May 4.
6
An Exploratory Survey for Understanding Perceptions, Knowledge and Educational Needs of General Practitioners (GSs) Regarding Autistic Disorders in New South Wales (NSW), Australia.一项探索性调查:了解澳大利亚新南威尔士州全科医生对自闭症谱系障碍的认知、知识和教育需求
J Clin Diagn Res. 2014 Jul;8(7):PC01-9. doi: 10.7860/JCDR/2014/8243.4527. Epub 2014 Jul 20.
7
Self-injurious behaviour in autistic children: a neuro-developmental theory of social and environmental isolation.自闭症儿童的自伤行为:一种社会与环境隔离的神经发育理论
Psychopharmacology (Berl). 2014 Mar;231(6):979-97. doi: 10.1007/s00213-013-3279-2. Epub 2013 Sep 21.
8
A review of complementary and alternative treatments for autism spectrum disorders.自闭症谱系障碍的补充和替代疗法综述。
Autism Res Treat. 2012;2012:870391. doi: 10.1155/2012/870391. Epub 2012 Nov 28.
9
[Psychopharmacology of autism spectrum disorders].[自闭症谱系障碍的精神药理学]
Nervenarzt. 2011 May;82(5):582-9. doi: 10.1007/s00115-010-3238-7.
10
Individual differences in vulnerability for self-injurious behavior: studies using an animal model.自我伤害行为易感性的个体差异:使用动物模型的研究
Behav Brain Res. 2011 Feb 2;217(1):148-54. doi: 10.1016/j.bbr.2010.10.012. Epub 2010 Oct 23.